Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Oct. 31, 2017
Oct. 31, 2016
Cash flows from operating activities:    
Net loss $ (7,120) $ (43,873)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization of property and equipment 1,758 2,289
Provision for inventory obsolescence 90 318
Amortization of intangible assets 1,839 2,519
Fair value of acquisition-related contingent consideration   249
Stock-based compensation expense 2,227 1,816
Deferred income taxes 102 14,649
Other (14) 113
Changes in operating assets and liabilities, excluding impact of acquisition:    
Accounts receivable (1,401) 1,987
Unbilled receivables 3,289 2,913
Inventories (165) 338
Prepaid expenses and other assets 62 428
Accounts payable (3,199) (2,102)
Accrued expenses 942 (4,833)
Deferred revenues 355 (3,864)
Other 327 173
Total cash used in operating activities (908) (26,880)
Cash flows from investing activities:    
Purchases of property and equipment (386) (521)
Purchases of marketable securities (7,246) (2,252)
Proceeds from sale and maturity of marketable securities 7,993 4,249
Acquisition of business, net of cash acquired   (5,243)
Other investing activities 176 28
Total cash provided by (used in) investing activities 537 (3,739)
Cash flows from financing activities:    
Proceeds from issuance of common stock 53 64
Payments of withholding tax on RSU vesting (52) (109)
Other financing activities   (4)
Total cash provided by (used in) financing activities 1 (49)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (878) (555)
Net decrease in cash, cash equivalents, and restricted cash (1,248) (31,223)
Cash, cash equivalents and restricted cash, beginning of period 28,411 58,815
Cash, cash equivalents and restricted cash, end of period 27,163 27,592
Supplemental disclosure of cash flow information:    
Income taxes paid $ 267 120
Supplemental disclosure of non-cash investing and financing activities:    
Asset group classified as held for sale   235
Transfer of items originally classified as inventories to equipment   24
DCC Labs [Member]    
Supplemental disclosure of non-cash investing and financing activities:    
Fair value of common stock issued for acquisition   2,640
Common Stock [Member]    
Supplemental disclosure of non-cash investing and financing activities:    
Fair value of common stock issued for deferred stock consideration obligation   $ 3,454